These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3830722

  • 1. Urinary pharmacokinetics of physostigmine in the rat.
    Somani SM, Boyer A.
    Eur J Drug Metab Pharmacokinet; 1985; 10(4):343-7. PubMed ID: 3830722
    [Abstract] [Full Text] [Related]

  • 2. Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration.
    Somani SM, Khalique A.
    Fundam Appl Toxicol; 1986 Feb; 6(2):327-34. PubMed ID: 3699321
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of biliary excretion of physostigmine in rat.
    Boyer AW, Somani SM.
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):180-92. PubMed ID: 4096611
    [Abstract] [Full Text] [Related]

  • 4. Hepatic and muscle clearance of physostigmine in the rat.
    Unni LK, Somani SM.
    Drug Metab Dispos; 1986 Dec; 14(2):183-9. PubMed ID: 2870892
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM.
    Biopharm Drug Dispos; 1989 Dec; 10(2):187-203. PubMed ID: 2706318
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
    Somani SM, Khalique A.
    Drug Metab Dispos; 1987 Dec; 15(5):627-33. PubMed ID: 2891478
    [Abstract] [Full Text] [Related]

  • 7. Disposition and metabolism of double-labeled [3H and 14C] N-methyl-2-pyrrolidinone in the rat.
    Wells DA, Digenis GA.
    Drug Metab Dispos; 1988 Dec; 16(2):243-9. PubMed ID: 2898341
    [Abstract] [Full Text] [Related]

  • 8. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog.
    Pfeifer CA, Bottoms GD, Johnson MA, Fessler J.
    Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
    Giacobini E, Somani S, McIlhany M, Downen M, Hallak M.
    Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
    [Abstract] [Full Text] [Related]

  • 10. Tissue distribution and elimination of [3H]levamisole in the rat after oral and intramuscular administration.
    Galtier P, Coche Y, Alvinerie M.
    Xenobiotica; 1983 Jul; 13(7):407-13. PubMed ID: 6659543
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of latanoprost in the cynomolgus monkey. 3rd communication: tissue distribution after topical administration on the eye studied by whole body autoradiography. Glaucoma Research Laboratories.
    Sjöquist B, Johansson A, Stjernschantz J.
    Arzneimittelforschung; 1999 Mar; 49(3):240-9. PubMed ID: 10219468
    [Abstract] [Full Text] [Related]

  • 12. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW, Ballantyne B, Leung HW.
    Toxicol Ind Health; 1998 Mar; 14(3):413-28. PubMed ID: 9569447
    [Abstract] [Full Text] [Related]

  • 13. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H, Matsunaga Y, Nambu K, Oh-e Y, Yoshida K, Hashimoto M.
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [Abstract] [Full Text] [Related]

  • 14. The disposition and pharmacokinetics of ketoconazole in the rat.
    Remmel RP, Amoh K, Abdel-Monem MM.
    Drug Metab Dispos; 1987 Mar; 15(6):735-9. PubMed ID: 2893696
    [Abstract] [Full Text] [Related]

  • 15. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 16. In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissues of rats.
    Somani SM, Dube SN.
    Life Sci; 1989 Oct; 44(25):1907-15. PubMed ID: 2739507
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of o-nitroanisole in Fischer 344 rats.
    Miller MJ, Sipes IG, Perry DF, Carter DE.
    Drug Metab Dispos; 1985 Oct; 13(5):527-31. PubMed ID: 2865097
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH, Cohn DA, Miller RR, Doss GA, Stearns RA, Simpson RE, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, tissue distribution, metabolism, and excretion of celecoxib in rats.
    Paulson SK, Zhang JY, Breau AP, Hribar JD, Liu NW, Jessen SM, Lawal YM, Cogburn JN, Gresk CJ, Markos CS, Maziasz TJ, Schoenhard GL, Burton EG.
    Drug Metab Dispos; 2000 May; 28(5):514-21. PubMed ID: 10772629
    [Abstract] [Full Text] [Related]

  • 20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.